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ABSTRACT 
 The antibiotic vancomycin was developed by Eli Lilly in the 1950s in response to 
the growing number of Staphylococcus aureus infections that were resistant to penicillin. 
Vancomycin was not widely used at the time because of its high toxicity. However, use 
of vancomycin in the United States has increased dramatically since the 1980s because of 
the emergence of methicillin resistant Staphylococcus aureus (MRSA) and Enterococcus 
species. There are three known mechanisms for vancomycin resistance: 1) target site 
modification by van genes, 2) biofilm formation, and 3) bacterial cell wall thickening. Of 
these mechanisms, target site modification is the most common. In this study, we  
analyzed cultivable highly vancomycin-resistant Gram-positive bacteria from the saliva 
of migratory songbirds, which were captured at the bird banding station at Fort Hays 
State University in previous work. Individual bacterial isolates were identified by partial 
16S rRNA sequencing. The majority of the identified bacteria were Staphylococcus 
succinus, with the majority being isolated from American Robin, which is commonly 
found in all of North America. Some of these bacteria carry vanA, vanB, and vanC genes 
and also have the ability to form biofilms. One of the van gene-carrying isolates is also 
coagulase-positive which is also considered a strong virulence factor. Given the wide 
range of the American Robin and ease of gene transfer between Gram-positive cocci, we 
postulate that these organisms could serve as a source of vancomycin resistance genes in 
human pathogens. 
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INTRODUCTION 
Vancomycin 
 Vancomycin, which is classified as a member of the glycopeptide antibiotic group, 
was isolated from Streptomyces orientalis by Eli Lilly and Company in 1952. They 
started clinical trials for vancomycin in human subjects and concluded that it was very 
effective against penicillin-resistant bacteria. Unfortunately, they also detected high 
toxicity of vancomycin to humans. The observed symptoms of vancomycin toxicity 
included ototoxicity, venous irritation, chills, and rash, which were thought to be largely 
due to impurities of vancomycin in those early preparations. Rapid infusion of 
vancomycin also caused “red man” or “red neck” syndrome which is characterized by a 
combination of erythema, pruritis, hypotension, and angioedema. By contrast, methicillin, 
the first semisynthetic penicillin, was less toxic than vancomycin, so vancomycin was 
reserved only for patients with severe infections (Levine, 2006). 
 The target site of vancomycin against bacteria is the dipeptide, D-Ala-D-Ala, on 
the pentapeptide within the peptidoglycan layer. Transpeptidase produced by bacteria 
recognizes the dipeptide (D-Ala-D-Ala) at the end of the pentapeptide chain, cleaves off 
the terminal alanine, and joins the remainder to the branch of a stem peptide from an 
adjacent polysaccharide chain. In another words, the transpeptidase is responsible for 
finalizing bacterial cell wall synthesis. Inhibition of this process by vancomycin leads to 
the destruction of the bacterial cell by osmotic pressure (Figure 1).
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Vancomycin Resistance - van Genes 
One of the major resistance mechanisms bacteria use against vancomycin is the 
vancomycin-resistance genes, which are called van genes. There are six well 
characterized van genes: vanA, vanB, vanC, vanD, vanE, and vanG. Bacteria carrying 
vanA, vanB, and vanD confer high levels of Minimum Inhibitory Concentration (MIC) 
against vancomycin. MIC is the term used to describe the lowest amount of antibiotic 
required to kill or inhibit organisms. Furthermore, vanA and vanB achieve very high 
vancomycin resistance (MIC= up to 1000 mg/L) (Courvalin, 2006). It has also been 
shown that the vanA gene also has the ability to confer high resistance to another member 
of the glycopeptide antibiotic group, teicoplanin (MIC= up to 512 mg/L) (Courvalin, 
2006). What vancomycin resistant organisms do is to change the sequence of the D-Ala-
D-Ala to D-Ala-D-Lac or D-Ala-D-Ser to prevent vancomycin binding (Figure 2). This 
decreases the affinity between the vancomycin and the dipeptide. The affinity between 
vancomycin and the precursor dipeptide D-Ala-D-Lac (for vanA, vanB, and vanD) is 
1000-fold lower than for the precursor dipeptide D-Ala-D-Ala. In the case of vanC, vanE, 
and vanG, the affinity between vancomycin and precursor dipeptide D-Ala-D-Ser is 6-
fold lower than for the precursor dipeptide D-Ala-D-Ala (Hong et al, 2008). Due to the 
much lower affinity, vanA, vanB, and vanD genes produce high levels of vancomycin 
resistance. Furthermore, the expression of vanA and vanB genes is inducible, and is the 
most frequently encountered type of glycopeptide resistance (Courvalin, 2006). The 
genes vanA, vanB, vanC, vanD, vanE, and vanG, are responsible for ligase function, 
which connects the amino acids and synthesizes dipeptide in the pentapeptide of 
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peptidoglycan layer. These vancomycin-resistance genes are only part of a key set of 
genes required to change the sequence of the dipeptide within the pentapetide. In other 
words, the existence of those van genes, vanA, vanB, vanC, vanD, vanE, and vanG, alone 
cannot change the sequence of dipeptide. The vancomycin-resistant bacterial strains 
usually carry a cluster of resistance genes which function to change the sequence of 
dipeptide targets. The main resistant genes which achieve the change of dipeptide 
sequence are vanH, which produces a dehydrogenase that converts pyruvate to D-Lac, 
vanA (or other ligase producing gene such as vanB) which catalyzes the formation of an 
ester bond between D-Ala and D-Lac, and vanX, a D,D-dipeptidase which hydrolyzes the 
dipeptide D-Ala-D-Ala synthesized by the host Ddl ligase enzyme (Figure 3) (Courvalin, 
2006). 
  These are common genes in vancomycin-resistance operons, but the resistance 
genes themselves in each operon are different. For instance, the vanB gene operon has 
vanW gene of unknown function, which the vanA operon does not carry (Figure 4). 
However, the most significant difference between the bacteria carrying the group of vanA 
and vanB operon and the vanD operon is the control of expression. Both the vanA and 
vanB operons are inducible, while the vanD operon is constitutive (Depardieu et al, 
2004a). 
Another difference between the group of vanA- and vanB- versus vanD- type strains is 
lack of D,D-dipeptidase activities. The vanA- and vanB-type strains require vanX 
activity to hydrolyze the dipeptide D-Ala-D-Ala synthesized by the host Ddl ligase, but 
the vanD-type strains do not require the vanX activity since the chromosomal ddl gene is 
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mutated, which means absence of an active D-Ala:D-Ala ligase. Consequently, the vanD-
type strains should grow only in the presence of vancomycin since they rely on the 
inducible resistance pathway for peptidoglycan synthesis (Figure 5) (Depardieu et al, 
2004a).  
 
Vancomycin Resistance-Biofilms 
 Another major vancomycin-resistance mechanism in some bacteria is biofilm 
formation, which slows the penetration of antibiotics to the cytoplasm of the bacterial cell. 
(Stewart, 2002 and Dunne et al, 1993). Biofilm formation is also known as one of the 
most threatening virulence factors researched by microbiologists because biofilm-
embedded bacteria are more resistant to antimicrobial agents and often cause chronic 
infections and sepsis in immunocompromised patients (Schlag et al, 2007). A major 
complication of biofilm formation is device-related infections, which are serious clinical 
problems today. The majority of hospital patients undergo procedures for the insertion of 
foreign devices, such as catheters, artificial heart valves, and joint replacements. Device-
related infections cause significant problems since the biofilm-embedded bacteria have 
resistance against many antimicrobial agents (Stewart, 2002).  
 In the case of Staphylococcus aureus, the biofilm is created by polysaccharide 
intercellular adhesin (PIA) which leads the bacteria to attach to, and accumulate on, host 
tissues.  Some bacteria involve other components to form biofilm. The control of biofilm 
formation is basically regulated by the quorum sensing mechanism, which allows bacteria 
to detect the density of their own species. Quorum sensing has also been shown to control 
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the stability of the three-dimensional biofilm structure (Bjarnsholt and Givskov, 2007). 
There are several advantages to the formation of biofilm by bacteria. First, bacteria 
embedded within biofilm are basically surrounded by exopolymer substance matrix 
(EPS) which creates pools of genes allowing for genetic acquisition and exchange by 
horizontal transfer, which leads to alteration of gene expression of bacteria within the 
biofilm, allowing them to become resistant to antibiotics. The EPS protects the bacteria 
inside the biofilm from attack by antibiotics. Furthermore, a decrease of bacterial growth 
within the biofilm increases resistance to antibiotics, enhancing survivability. 
(Clutterbuck et al, 2007). Scientists have researched the mechanisms of biofilm formation 
because many genes are involved in the process. The genes related to biofilm formation 
are different between various bacterial strains, so that biofilm formation is a very 
complex process.  
 Quorum sensing is also related to autolysis, which is responsible for the 
destruction of the cell wall and subsequent cell lysis. Biofilm formation requires 
extracellular DNA (eDNA) for stability and development. Autolysis destroys the 
bacterial cell wall, leading to the release of eDNA from the dead cell, which is 
subsequently used for construction of the biofilm by the living cells that remain (Rice et 
al, 2007). Autolysis also plays a role in cell wall thickening, which is another mechanism 
used by some bacteria to resist vancomycin (Gazzola and Cocconcelli, 2008).  
 The cell wall thickening process basically thickens the peptidoglycan layer in the 
bacterial cell. For Gram-positive bacteria, the peptidoglycan layer is composed of glycan 
chains that are constructed by alternating N-acetylmuramic acid (NAM) and N-
           6 
 
 
 
acetylglucosamine (NAG) subunits. Tetrapeptides, which extend from the NAM subunits 
of the glycan chains, act as anchor points for peptide interbridges, allowing the glycan 
chains to be linked together to form a three-dimensional meshwork (Hiramatsu, 2001). 
According to Sieradzki and Tomasz, some vancomycin-resistant Staphylococcus aureus 
(VRSA) strains stop the autolysis process in the presence of vancomycin, so the cell wall 
becomes thickened (1997). In this work, investigators cultured VRSA in growth media 
containing vancomycin to measure the decrease of the vancomycin concentration during 
bacterial growth. According to these experiments, the concentration of the vancomycin in 
the media decreased gradually as the bacterial growth increased (Sieradzki and Tomasz, 
1997). According to Cui et al (2006), the thickness of cell wall for vancomycin-
intermediate Staphylococcus aureus (VISA) strain Mu50, was 35.02 nm, which is 1.64 
times thicker than the cell wall of vancomycin-susceptible Staphylococcus aureus 
(VSSA). It was demonstrated that vancomycin clogs the bacterial peptidoglycan layer, 
which prevents further penetration of subsequent vancomycin molecules (Cui et al, 2006). 
The thickening cell wall correlates with an increase of vancomycin MIC.  These 
investigators also detected that the vancomycin MIC of those strains decreased under the 
vancomycin-free environment (Cui et al, 2003). Some of the VRSA strains lost the 
vancomycin-resistance phenotype under the antibiotic-free condition so these workers 
postulated that these bacteria somehow use the vancomycin (Cui et al, 2003).  
 
Vancomycin-Resistant Pathogens- VRE and VRSA  
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 Two of the major pathogenic groups of bacteria that exhibit vancomycin 
resistance are vancomycin-resistant enterococci (VRE) and vancomycin-resistant 
Staphylococcus aureus (VRSA). A certain type of VRE is called vancomycin-dependent 
Enterococcus (VDE) because it requires vancomycin for cell wall synthesis. 
Vancomycin-resistant strains usually change the amino acid structure of their cell walls to 
avoid the interaction between vancomycin and the cell wall components, which 
essentially leads to vancomycin inactivation (Bambeke et al, 1999). In other words, VDE 
strains cannot survive without vancomycin because of mutation of the ddl gene. As 
mentioned previously, the chromosomal ddl gene is responsible for D-Ala:D-Ala ligase 
function which synthesizes the dipeptide for bacterial cell walls. Mutation of the 
chromosomal ddl gene means inactivation of synthesis of the dipeptide for bacterial cell 
wall formation. In another words, the bacteria cannot synthesize bacterial cell walls 
unless other genes synthesize the bacterial cell wall dipeptide, replacing the function of 
the defective ddl gene. Consequently, VDE strains substitute the dipeptide, D-Ala-D-Lac 
or D-Ala-D-Ser, synthesized by van genes for bacterial cell wall synthesis since 
vancomycin activates van genes (Bambeke et al, 1999). Another phenomenon similar to 
vancomycin dependence in VDE has been reported by Dantas et al who demonstrated 
some bacteria have the ability to survive on antibiotics as their sole carbon sources (2008).  
 Another serious vancomycin-resistant organism is vancomycin-resistant 
Staphylococcus aureus (VRSA), which is related to methicillin-resistant Staphylococcus 
aureus (MRSA). Methicillin was introduced in Europe in 1959 and in the United States 
in 1961, and the first reported case of MRSA was in the United Kingdom in 1961. The 
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first reported case of MRSA in the United States was in 1968. MRSA is currently known 
as one of major pathogens in hospitals all over the world (Rice, 2006). According to a  
meta-analysis report in 2008,  the overall mortality rate caused by MRSA infection was 
over 50%. In two of those analysis cases, it was over 70% (Dancer, 2008). In the United 
States, 59.5% of ICU patients were infected with MRSA according to the National 
Nosocomial Infections Surveillance (NNIS) system report for 2004. Furthermore, that 
number represented an 11% increase of MRSA infections during the period 1998 to 2002 
(Rice, 2006). Vancomycin is currently the drug of choice for MRSA infections, but the 
use induces emergence of VRSA and vancomycin intermediate Staphylococcus aureus 
(VISA) (Jones, 2008).  
 The first reported case of VRSA was in 1996 in Japan. In the United States, the 
first four cases of VISA were reported between 1997 and 1999 (Rice, 2006). The 
mortality rate of the patients who acquired VISA was 63% (Dancer, 2008). A main 
difference between VISA and VRSA is the MIC. The MIC of vancomycin against VISA 
strains is 8 to 16 mg /L, whereas in the case of VRSA it is 64 mg/L. Another main 
difference is the mechanism of resistance against vancomycin. For VISA strains, the cell 
wall thickens, which causes it to trap the vancomycin molecule in the outer layer of the 
cell wall, thereby limiting access to the cytoplasmic membrane where the functional 
targets of vancomycin are located. In the case of VRSA strains, the organisms carry 
vancomycin resistance genes such as vanA, which produces an enzyme to change the 
dipeptide sequence of bacterial cell wall, and involves horizontal transfer of transposons 
from VRE (Rice, 2006). 
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 Both MRSA and VRSA originally came from Staphylococcus aureus which can 
inhabit the surface of human skin or nasal passages as normal flora. VRSA strains carry 
vancomycin resistance genes, and MRSA strains carry many antibiotic resistance genes. 
Many of today’s MRSA strains have tolerance to vancomycin. Staphylococcus aureus 
produces many toxins such as α-toxin, staphylococcal toxic shock syndrome toxin 
(STSST), enterotoxins, and Panton-Valentine leucocidin (PVL). For instance, PVL 
strains cause specific human infections such as necrotizing pneumonia, where the 
mortality rate is up to 75%. Furthermore, some of these toxins are enhanced by use of 
certain antibiotics such as members of the ß-lactamase antibiotic group (Dancer, 2008). 
Normally, infections caused by Staphylococcus aureus are treated by antibiotics, but it is 
difficult to treat with antibiotics if the infection is caused by MRSA, since MRSA is 
resistant to many antibiotics. Furthermore, it has been reported that certain MRSA strains 
are resistant to the newest antibiotic, linezolid (Arias et al, 2008). According to that 
report, a 52-year-old female acquired a MRSA infection during a surgical procedure, and 
the hospital prescribed six different antibiotics which are relatively powerful antibiotics. 
However, the patient died of the infection at day 27 because of multi-organ failure (Arias 
et al, 2008). There are two key antibiotics used in the treatment of MRSA infections: 
vancomycin and linezolid. Although linezolid is one of the newest antibiotics, MRSA 
quickly became resistant to it according to that report (Arias et al, 2008). Due to the 
ability to rapidly develop tolerance to new antibiotics, and to produce many types of 
toxins, MRSA is currently known as one of the most serious pathogens in hospitals.  
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Coagulase-Negative Staphylococci 
 Staphylococci are conveniently divided into two groups based on the production 
of the enzyme coagulase. These are called coagulase-positive staphylococci (CPS) and 
coagulase-negative staphylococci (CNS). Coagulase is the enzyme that acts with a blood 
plasma factor to convert fibrinogen to a fibrin clot (Ryan and Ray, 2010). Staphylococcus 
aureus, including MRSA, is classified as a CPS. The CNS organisms are known as starter 
cultures for fermented food products and as opportunistic pathogens rather than as frank 
pathogens. For instance, Staphylococcus succinus and Staphylococcus equorum are both 
classified as CNS and are either associated with foods, or play a major role in the food 
processing industry. One of main advantages of starter cultures in food processing is that 
the fermentation and the ripening process can be carried out under controlled conditions 
(Zell et al, 2008). The CNS organisms are also known as normal flora of warm-blooded 
animals such as birds and mammals, including humans (Irlinger, 2008 and Place et al, 
2002). For this reason, most CNS strains are thought of as being beneficial 
microorganisms rather than virulent pathogens. 
 However, some CNS strains can cause severe infections, especially in 
immunocompromised people, and are often difficult to treat because they are relatively 
antibiotic-resistant (Zell et al, 2008). For example, the oxacillin resistance of CNS lies 
between 70% and 80% according to reports from different parts of Europe (Diekema et al, 
2001). Similar rates were also observed in the USA, Canada, and Latin America. In a 
report by Dar et al, it was shown that 22.5% of CNS isolates from 750 human subjects 
were resistant to methicillin (2006). Furthermore, an antibiotic-induced SOS response 
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promotes horizontal dissemination of pathogenicity island-encoded virulence factors in 
staphylococci (Ubeda et al, 2005). Those virulence factors include toxins such as 
hemolysins α,ß,γ, and δ, leukocidin, exfoliative toxins A and B, toxic shock syndrome 
toxin-1 (TSST-1), and a family of emetic pyrogenic superantigens (Zell et al, 2008). 
 In previous work in our lab, sixteen Gram-positive vancomycin-resistant cocci 
strains were isolated from the oral cavities of birds caught at the bird banding station on 
the campus of Fort Hays State University. These birds included eight American Robins 
(Turdus migratorius), three Orange-Warblers (Vermivora celata), and one each of 
Carolina Wren (Thryothorus ludovicianus), Least Flycatcher (Empidonax minimus), 
Swainson’s thrush (Catharus ustulatus), and Mourning warbler (Oporornis philadelphia) 
(Bitner, 2008). 
 Those bacterial isolates were identified from the partial sequencing of the 16S 
rRNA gene.  The closest match to fourteen of the isolates was Staphylococcus succinus 
AF004219, while the closest matches to the other two isolates were Staphylococcus 
saprophyticus and Enterococcus gallinarum. The MIC of vancomycin isolates was ≥ 256 
µg /mL, and three of the isolates were shown to be coagulase-positive by the tellurite 
glycine agar method (Bitner, 2008).  
 In this study, I assayed those sixteen previously isolated Gram-positive 
vancomycin-resistant cocci for the presence of van genes and the ability to produce 
biofilm. I found van genes, vanA, vanB, and vanC in several of these organisms. In 
addition, some of the isolates were also shown to have the ability to produce biofilm, 
which may be considered a significant virulence factor. However, the CNS strains are 
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usually not major pathogens, as mentioned earlier. A major concern of the CNS strains is 
that they could transfer virulence factors to other bacteria by horizontal gene transfer, 
leading to wide dispersal. Since the CNS are staphylococci, the virulence factors could be 
easily transferred to other more virulent Staphylococcus strains, such as MRSA.  
 Another major concern raised by this study is that the vancomycin-resistant 
organisms were isolated from birds that are commonly found all over North, Central, and 
parts of South America (Aldrich and James, 1991). The extensive habitat of these animals 
could allow them to serve as vectors to widely disseminate vancomycin-resistance genes 
in the environment. To the best of my knowledge, this is the first report of van genes 
being found in a staphylococcal species other than Staphylococcus aureus and the first 
report of vanB in a bacterial genus other than Enterococcus. 
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MATERIALS AND METHODS 
 
Organisms For This Study 
 I focused on the 16 vancomycin-resistant Gram-positive cocci previously isolated 
from wild song birds at the bird banding station at Fort Hays State University (Bitner, 
2008). 
 
Genomic DNA Isolation 
 Pure cultures of the bacteria were inoculated in 4.0 mL of tryptic soy broth (Difco, 
Detroit, Michigan, USA) and incubated for 12 hours at 37° C. Bacterial genomic DNA 
was isolated from the overnight cultures by using the protocol from Ausbel et al. (1997). 
The steps of the protocol were performed as follows: 1) 1.5 mL of overnight culture were 
centrifuged at 12,000 rpm for two minutes and the supernatant was removed; 2) The 
pelleted cells were resuspended in 567 µL of TE buffer (10mM Tris·Cl, and 1mM 
EDTA)  buffer by repeated pipetting; 3) 30 µL of 10% SDS and 3µL of 20 mg/mL 
proteinase K were added into the mixture and the mixture was incubated at 37° C  for one 
hour; 4) 100 µL of 5M NaCl were added and mixed thoroughly and 80µL of CTAB/NaCl 
solution (10% hexadecyltrimethyl ammonium bromide (CTAB)/0.7M NaCl) was added 
into the mixture and the mixture was incubated at 65 °C for 10 minutes; 5) 780 µL of 
chloroform/isoamyl alcohol (24:1) was added, mixed, then centrifuged at 12,000 rpm for 
five minutes; 6) the aqueous (top) layer was transferred to a fresh 1.5 mL centrifuge tube 
and 600 µL of phenol/chloroform/isoamyl alcohol (25:24:1) were added, mixed, and 
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centrifuged at 12,000 rpm for five minutes; 7) the aqueous layer was transferred into a 
fresh 1.5 mL microcentrifuge tube and 300 µL of isopropanol were added and mixed 
until DNA precipitated; 8) the mixture was centrifuged at 12,000 rpm for five minutes 
and the supernatant was removed; 9) the pelleted DNA was washed carefully by adding 1 
mL of  70% ethanol then centrifuged at 12,000 rpm at five minutes; 10) the supernatant 
was removed and the pelleted DNA was dried by vacuum centrifugation until all traces of 
ethanol had been removed. The pellet was resuspended in 100 µL of sterile water and 
stored at -20° C. The final product was confirmed by agarose gel electrophoresis by using 
10 µL of purified DNA and 3.0 µL of orange G loading dye. A 1.0% agarose gel in 1X 
TAE buffer (0.04 M Tris-Acetate and 0.001 M EDTA) was used with electrophoresis 
conditions of 90 volts for one hour. Samples were run next to the 1kb DNA ladder 
(Promega Corporation, Madison, Wisconsin). The agarose gel was stained with ethidium 
bromide, and viewed by using the Gel Logic 100 gel documenter (Eastman Kodak 
Company, Rochester, New York). 
 
Polymerase Chain Reaction 
 The presence of van genes was detected by the polymerase chain reaction (PCR), 
using the extracted genomic DNA as the template, and specific primers for the vanA, 
vanB, vanC, and vanD genes. The primers used for PCR were EA1 (vanA forward), EA2 
(vanA reverse), EB3 (vanB forward), EB4 (vanB reverse), EC5 (vanC forward), EC8 
(vanC reverse), ED1 (vanD forward), ED2 (vanD reverse) (Depardieu et al, 2004b) 
(Table 1). The annealing temperatures for the reactions were based on the protocol 
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followed by Depardieu  et al (2004b), which was 54° C. The following components for 
PCR were combined in a 0.5mL centrifuge tube: 39.5 µL sterile water, 5.0 µL standard 
Taq reaction buffer, 1.0 µL deoxynucleotide solution (dNTP) mix (containing 
deoxyadenosine triphosphate, deoxycytosine triphosphate, deoxyguanine triphosphate, 
and deoxythymine triphosphate, each at a 10 mM concentration), 0.5 µL bovine serum 
albumin, 0.5 µL Triton X-100, 0.5 µL forward primer, 0.5 µL reverse primer, 2.0 µL 
template DNA, and 0.5 µL Taq DNA polymerase. The PCR reaction was performed in a 
thermocycler using the following conditions: 94° C for three minutes, 40 cycles of 94° C 
for one minute, 54° C for 1 minute, and 72° C for 1 minute; the final elongation step was 
72° C for seven minutes.  
 
Detection of van Genes 
 The presence of PCR products was verified using agarose gel electrophoresis, 
using 20 µL of amplified DNA and 3.0 µL of orange G loading dye per well. A 3.0% 
agarose gel in 1X TAE buffer was used with electrophoresis conditions of 90 volts for 
100 minutes. Samples were run next to the 100bp DNA ladder (Promega, Corporation, 
Madison, Wisconsin). The agarose gel was stained using the ethidium bromide, and 
viewed by using the Gel Logic 100 documentation system (Eastman Kodak Company, 
Rochester, New York). The amplified vancomycin resistance genes were compared to 
positive control PCR products from bacterial strains known to carry various van genes. I 
used Enterococcus faecalis SFV1 as the positive control for vanA from Dr. Susan 
Flannagan at the University of Michigan (Ann Arbor, Michigan), Enterococcus faecalis 
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V583 as positive control for vanB, and Enterococcus gallinarum ATCC 49579 as the 
positive control for vanC from Dr. Ludek Zurek at Kansas State University (Manhattan, 
Kansas).  
 
Crystal Violet Assay 
 One method used for the detection of biofilm was Crystal Violet Assay (CVA) 
(Toledo-Arana et al, 2001). Pure cultures of each organism were inoculated in 4.0 mL of 
TSB (Difco, Detroit, Michigan, USA) and grown for 12 hours at 37°C. Staphylococcus 
epidermidis ATCC 35984 and Staphylococcus epidermidis ATCC 12228 were used as 
positive and negative controls respectively in this assay. The steps of the protocol were 
performed as follows: 1) 200 µL of the bacterial cell suspension were used to inoculate a 
well in a sterile 96-well polystyrene microtiter plate (Fisher, Hanover Park, Illinois, 
USA). After 24 hours of incubation at 37°C, the bacterial suspension was removed; 2) 
The wells were gently washed three times with 200 µL phosphate-buffered saline (PBS); 
3) The wells were dried at 50-60° C for one hour using Isotemp Vaccum Oven Model 
280A; 4) The wells were stained with 200µL of 1% aqueous crystal violet for 20 minutes; 
5) The wells were rinsed  with deionized water; 6) The wells were fixed by ethanol-
acetone (80:20, vol/vol); 7) The optical density at 550-590nm was determined using a 
microtiter plate reader (Sunrise, Salzburg, Austria).  
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Scanning Electron Microscopy 
 Specimens were prepared for scanning electron microscopy as described in 
Thurlow and Gillock (2005). Briefly, specimens were grown overnight in trypticase soy 
broth at 37°C. Samples were vacuum filtered through 0.45 µm HA filters (Millipore 
Corporation, Billerica, Massachusetts). Filters containing the specimens were fixed in 
0.15 M cacodylate buffer and 1% glutaraldehyde overnight. Filters were washed in a 
graded series of 95% ethanol and sterile distilled water for 15 minutes at each step (10% 
ethanol, 25% ethanol, 50% ethanol, 75% ethanol, 100% ethanol). Samples remained in 
ethanol for at least 24 hours. The filters were then dried in two steps by using 
hexamethyldisalazane (HMDS) and 95% ethanol (Step 1, 50% and HMDS 50% ethanol 
for 15 minutes: Step2, 100% HMDS until completely evaporated). Filters containing 
specimens were cut and mounted on a brass plate by using silver cement. The brass plates 
were fixed to an aluminum stub using silver cement. The specimens were coated with a 
layer of gold-palladium in a Pelco sputter coater for 1 minute. Specimens were viewed 
using ISI SX-30 scanning electron microscope (Topcon America Corporation, Paramus, 
New Jersey). 
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RESULTS 
van Gene Detection by PCR 
 The PCR assay indicated that five of the 14 Staphylococcus succinus isolates 
carried the vanA gene alone (Figure 6 and Table 2). In these organisms, PCR products of 
732 bp in length were detected, clearly indicating the presence of the vanA gene. In 
Figure 6, positive results from Staphylococcus succinus isolates V22 and V45 are shown. 
One of the Staphylococcus succinus isolates, V46, was demonstrated to carry three van 
genes; vanA, vanB, and vanC (Figure 7 and Table 2). One isolate, Enterococcus 
gallinarum, or V49 appears to carry vanC alone (Figure 8 and Table 2). 
 
Biofilm Detection  
 Three of 14 Staphylococcus succinus isolates from American Robin, Mourning 
Warbler, and Least Flycatcher were shown to have the potential to form biofilm 
according to the results of the crystal violet assay. The density of crystal violet, as 
determined by absorbance at 620 nm, in the well for V56 is very similar to that of the 
well for the positive control, indicating V56 has the ability to form biofilm. (Figure 9 and 
Table 2). Biofilm was directly observed via scanning electron microscopy examination of 
one of the 14 Staphylococcus succinus isolates (Figure 10). The negative control strain 
for biofilm formation, Staphylococcus epidermidis ATCC 12228, clearly did not 
demonstrate the presence of biofilm (Figure 11). Conversely, biofilm formation was 
readily seen in the positive control strain for biofilm formation, Staphylococcus 
epidermidis ATCC 35984 (Figure 12).   
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DISCUSSION 
 Previous work indicated that 14 of 16 vancomycin-resistant bacterial isolates from 
six different birds species were Staphylococcus succinus according to 16S rRNA 
identification. One of the isolates was Enterococcus gallinarum, while the other was 
Staphylococcus saprophyticus from the American Robin (Bitner, 2008). 
 Enterococci are a common nosocomial urinary tract and wound infection agent, 
and the third most common cause of nosocomial bacteremia in the United States. Many 
enterococci species are known as serious nosocomial pathogens since they can cause 
endocarditis and meningitis, and show intrinsic resistance against common antibiotics 
such as penicillin and fluoroquinolones. Due to the intrinsic resistance of enterococci to 
common antimicrobials, vancomycin was often used for the treatment, which ultimately 
led to vancomycin-resistant Enterococcus (VRE) (Cetinkaya et al, 2000). Enterococcus 
gallinarum is not commonly known as a serious nosocomial pathogen. However, this 
organism eventually became a vancomycin-resistant strain called vancomycin resistant 
Enterococcus gallinarum (VREG) which caused a nosocomial outbreak in a Colombian 
teaching hospital in 2004 (Contreras et al, 2008). In this case, the main clinical 
syndromes were bloodstream infections and surgical site infections. Unfortunately, 
Contreras et al could not detect the presence of any virulence-associated genes from 
VREG isolated from the outbreak (2008). However, they hypothesized that the VREG 
strain had the ability to produce serious infections and disseminate across the hospital 
environment since the outbreak did occur. They also did not detect the presence of any of 
the virulence factors from Enterococcus faecalis and Enterococcus faecium so they 
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suggest that VREG strains or unexplored pathogens carry virulence genes and facilitate 
horizontal transfer of antimicrobial resistance genes across bacterial populations 
(Contreras, 2008). Another study suggested that Enterococcus gallinarum might be the 
original strain which carries the vanC gene intrinsically because of the degree of identity 
of the sequence (Gholizadeh and Courvalin, 2000) so that Enterococcus gallinarum from 
this study is not rare. However, the MIC against vancomycin of this isolate from this 
study was shown to be ≥ 256 µg/mL, which means that this isolate should have other 
mechanisms to tolerate such a high amount of vancomycin, since the usual resistance 
capability of vanC-carrying organisms is 2-32 µg/mL (Cetinkaya et al, 2000). 
 One vancomycin-resistant isolate from this study was Staphylococcus 
saprophyticus, which is classified as a CNS, and is usually considered normal microflora, 
but can also cause medical risk. Staphylococcus saprophyticus may contribute to sausage 
aroma formation and help to prevent off-flavor during normal sausage ripening, but this 
strain also causes acute urinary tract infection (UTI) (Irlinger, 2008) and can be an agent 
of nosocomial and bloodstream infections (Zell et al, 2008). This strain accounts for up to 
42% of all UTI in young women (Eiff et al, 2002). Several studies have reported that 
some Staphylococcus saprophyticus strains are vancomycin-resistant (Alamo et al, 1999). 
To my knowledge, however, this is the first report of a  Staphylococcus saprophyticus 
strain which carries the vanA gene and has a vancomycin MIC of ≥ 256 µg/mL. 
 Most of the vancomycin-resistant bacterial isolates previously found in wild 
songbirds by Bitner were Staphylococcus succinus (2008). This microorganism is 
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normally associated with foods or plays a major role in the food processing industry, and 
is not usually considered a pathogen (Resch et al, 2008).  
 However, the opportunistic CNS can cause severe infections since they are 
relatively muti-drug resistant, as mentioned previously.  In a study by Resch et al, they 
chose 21 antibiotics for assessment of resistance in the CNS organimsms Staphylococcus 
succinus and Staphylococcus xylosus (2008). They showed 90% of the assayed strains of 
these organisms exhibited resistance to the chosen antibiotics. Furthermore, some of the 
Staphylococcus succinus strains were resistant to up to four different antibiotics. 
However, none of their Staphylococcus succinus strains were resistant to vancomycin. 
They also observed differences in antibiotic resistance in CNS organisms isolated from 
different foods. Of the CNS organisms isolated from foods, 87% of those from hard and 
soft cheeses, 83% from sausage, and 93% from meat starter cultures exhibited high levels 
of resistance, whereas only 19% of the CNS organisms isolated from fermented fish were 
resistant (Resch et al, 2008). These investigators could not determine what factors affect 
the tolerance of antibiotic resistance in different foods. The MIC against vancomycin of 
most of the Staphylococcus succinus strains from this study was ≥ 256 µg/mL, indicating 
they are clearly vancomycin resistant, since the NCCLS (National Committee for Clinical 
Laboratory Standards) considers vancomycin-resistant microorganisms are those in 
which the MIC is above 32 µg/mL (Walsh and Howe, 2002).   
Furthermore, some of the isolates in my study were found to be carrying either 
vanA, vanB, or vanC. The vanA and vanB resistance genes are both inducible and have 
only been reported to exist in plasmid DNA (Courvalin, 2006). vanA overcomes 
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vancomycin up to 1000 µg/mL and teicoplanin, in the same antibiotic group of 
vancomycin, up to 512 µg/mL, whereas vanB overcomes vancomycin up to 1000 µg/mL 
and teicoplanin up to 1 µg/mL (Gholizadeh and Courvalin, 2000). As mentioned in the 
introduction section, vancomycin is one of the critical antibiotics for today’s antibiotic 
treatment, but the high MIC of these resistant organisms are absolutely toxic for human 
since vancomycin is a strong antibiotic with many potential side effects. The ingestion of 
18.0-47.0 µg/mL of vancomycin during treatment was observed to cause tinnitus, rash, 
neutropenia, and possible nephrotoxicity as side effects (Levine, 2006).  
 Three isolates from my study were shown to cause biofilm formation by CVA, 
which is known as a serious virulence factor because biofilm treatment is limited and is 
the leading cause of infection related to implanted medical devices (IMDs) (McCann et al, 
2008). The biofilm adheres to abiotic objects such as IMDs and functions to cover the 
bacteria so that they can grow on the surface of the objects, while avoiding the host 
immune system and antibiotics. In some instances, biofilm-encased bacteria are dislodged 
into the circulatory system, which causes bacteremia. One of the major biofilm formation 
species is Staphylococcus epidermidis. In the case of Staphylococcus epidermidis, 
antibiotics might kill planktonic bacteria shed from the biofilm surface, but they fail to 
eradicate those embedded within the biofilm, which can then subsequently act as a 
reservoir for recurrent infection. Following antibiotic treatment, a minority of drug-
resistant bacteria survive that repopulate the biofilm, with the survivors becoming much 
more antibiotic resistant (McCann et al, 2008). To overcome colonization and infections, 
many researchers and manufacturers have explored various surface technologies using 
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antimicrobial biomaterials. However, several researchers have raised concern that 
antimicrobial loading into a device by coating or immersion is a major driving force for 
the generation of resistance. To date, the only way to avoid the problems of creating 
resistant strains is the surgical removal of biofilm-coated objects. Bacteremia caused by 
biofilm-forming bacterial strains is a significant medical risk in hospitals (McCann et al, 
2008).    To the best of my knowledge, this is the first report of any van genes being 
found in a staphylococcal species other than Staphylococcus aureus as well as the first 
report of the vanB in a bacterial genus other than Enterococcus. 
 Another key concern raised from this study is the isolation of extremely 
antibiotic-resistant organisms from highly mobile wild songbirds. The majority of birds 
which carried the highly vancomycin-resistant bacteria from this study were American 
Robins, which are migratory and cover most of North, and portion of Central, and parts 
of Northern South America (Aldrich and James, 1991). Since many American Robins 
appear to carry Staphylococcus succinus, it is conceivable that the bacterium is a normal 
flora microorganism of the American Robin. If this is the case, the American Robin could 
act as a vector animal to spread vancomycin-resistance genes over a wide range. Birds 
acting as vector animals for pathogens are not unusual. There are numerous examples of 
organisms such as bacteria, viruses, fungi, and parasites being spread over wide distances 
by birds (Tsiodras et al, 2008). For instance, avian influenza and West Nile Virus (WNV) 
are well known to be transported by birds. The 2009 outbreak of H1N1 influenza A is a 
particularly widely publicized example. In that case, the birds were also acting as media 
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animals, which facilitated the alteration of the viral antigens, causing antigenic shift, and 
creating more virulent viruses (Gatherer, 2009 and Patel et al, 2010). 
 Since bacteria freely participate in horizontal gene transfer, it is possible that the 
relatively innocuous highly vancomycin-resistant isolates from this study could transfer 
resistance genes to other more virulent microorganisms such as MRSA.  According to 
Resch et al, CNS strains could have a high incidence of transfer of antibiotic-resistance 
genes to other staphylococci because of close phylogenetic relationships (2008). MRSA 
is a significant pathogenic agent in hospitals. It has had a severe impact upon the 
nosocomial infection mortality rate. The average mortality rate of MRSA from meta-
analysis was ~36% compared to a mortality rate of ~24% from septicemia caused by 
methicillin-susceptible Staphylococcus aureus (MSSA). Furthermore, seven of the 
studies quoted MRSA bacteremia mortality rates over 50%, and two of these were over 
80%. In the case of the patients who are infected with vancomycin-intermediate 
Staphylococcus aureus (VISA), the mortality is even higher (78%) (Dancer, 2008).  
 Additional research is needed to verify whether free-living wild song birds are 
really vector animals for vancomycin-resistance genes and whether vancomycin-resistant 
Staphylococcus succinus should be considered normal flora in the American Robin. 
Further research is also required to identify and understand the mechanisms of 
vancomycin-resistance used by bacteria in the absence of van genes or biofilm formation, 
as was seen in isolates V47, V67, V166, V170, V183, and V186 (Table 2). It is possible 
that these organisms are utilizing a cell wall thickening mechanism, or could be using a 
vancomycin-resistance pathway not yet reported in the literature.   
           25 
 
 
 
LITERATURE CITED 
Alamo, L., Cereda R. F., Tosin, I., Miranda, E. A., and Sader, H. S. 1999. Antimicrobial 
Susceptibility of Coagulase-Negative Staphylococci and Characterization of 
Isolates with Reduced Susceptibility to Glycopeptides. Diagnostic Microbiology 
and Infectious Disease. 34:185-191. 
Aldrich, J. W., and James, F. C. 1991. Ecogeographic Variation in the American Robin 
 (Turdus migratorius). University of California Press. 108:230-249. 
Arias, C. A., Vallejo, M., Reyes, J., Panesso, D., Moreno, J., Castaneda, E., Villegas, M. 
V., Murray, B. E., and Quinn, J. P. 2008. Clinical and Microbiological Aspects 
of Linezolid Resistance Mediated by the cfr Encoding a 23S rRNA 
Methyltransferase. Journal of Clinical Microbiology. 46:892-896. 
Ausbel, F., Brent., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, 
K. Editors, 1997. Short Protocols in Molecular Biology, Third Edition. John 
Wiley and Sons Inc. 
Bambeke, F. V., Murielle, C., Reynolds P. E., Fraimow, H. S., and Courvalin, P. 1999. 
Vancomycin-Dependent Enterococcus faecalis Clinical Isolates and Revertant 
Mutants. Antimicrobial Agents and Chemotherapy. 43:41-47. 
Bitner, J. J. Survey of antibiotic-resistant bacteria carried in the oral cavities of migratory 
songbirds in western Kansas. Master’s thesis. Department of Biological 
Sciences. Fort Hays State University. 2008. 
           26 
 
 
 
Bjarnsholt, T., and Givskov, M. 2007. Quorum-sensing blockade as a strategy for 
enhancing host defences against bacterial pathogens. Philosophical Transactions 
of The Royal Society.362:1213-1222. 
Cetinkaya, Y., Falk, P., and Mayhall, Glen. 2000. Vancomycin-Resistant Enterococci. 
Clinical Microbiology Reviews. 13:686-707. 
Clutterbuck, A. L., Woods, E. J., Knottenbelt, D. C., Clegg, P. D., Cochrane, C. A., and 
Percival, S. L. 2007. Biofilms and their relevance to veterinary medicine. 
Veterinary Microbiology. 121:1-17. 
Contreras, G. A., DiazGranados, C. A., Cortes, L.,  Reyes, J.,  Vanegas, S., Panesso, D., 
Rincon, S., Diaz, L., Prada, G., Murray, B. E., Arias, C. A. 2008. Nosocomial 
outbreak of Enterococcus gallinarum: untaming of rare species of enterococci. 
Journal of Hospital Infection. 70:346-352. 
Courvalin, P. 2006. Vancomycin Resistance in Gram-Positive Cocci. Clinical Infectious 
Diseases. 42:25-34.  
Cui, L., Iwamoto, A., Lian, J., Neoh, H., Maruyama, T., Horikawa, Y., and Hiramatsu, K.           
2006. Novel Mechanism of Antibiotic Resistance, Originating in Vancomycin-
Intermediate Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 
52:428-438 
Cui, L., Ma, X., Sato, K., Okuyama, K., Tenover, F. C., Mamizuka, E. M.,  Gemmell, C. 
G., Kim, M., Ploy, M., Solh, El. N., Ferraz, V., and Hiramatsu, K. 2003.  Cell 
Wall Thickening Is a Common Feature of Vancomycin Resistance in 
Staphylococcus aureus. Journal of Clinical Microbiology. 41: 5-14. 
           27 
 
 
 
. 
Dancer, S. J,. 2008 The effect of antibiotics on methicillin-resistant Staphylococcus 
aureus. Journal of Antimicrobial Chemotherapy. 61:246-253 
Dantas, G., Sommer, M. O., Oluwasegun, R. D., Church, G. M. 2008. Bacteria Subsisting 
on Antibiotics. Science. 320:100-102. 
Dar, J. A., Thoker, M. A., Khan, J. J., Ali, A., Khan, M. A., Rizwan, M., Bhat, K. H., Dar, 
M. J., Ahmed, Niyaz., and Ahmad, S. 2006. Molecular epidemiology of clinical 
and carrier strains of methicillin resistant Staphylococcus aureus (MRSA) in the 
hospital settings of north India. Annals of Clinical Microbiology and 
Antimicrobials. 22:1-15. 
Depardieu, F., Kolbert, M., Pruul, H., Bell, J., and Courvalin, P. 2004a. vanD-Type 
Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis. 
Antimicrobial Agents and Chemotherapy. 48:3892-3904. 
Depardieu, F., Perichon, B., and Courvalin, P. 2004b. Detection of the van Alphabet and 
Identification of Enterococci and Staphylococci at the Species Level by 
Multiplex PCR. Journal of Clinical Microbiology. l42:5857-5860. 
Diekema D. J., Pfaller, M. A., Schmitz, F. J.,  Smayevsky, J., Bell, J, Jones R. N., Beach, 
M., and the SENTRY Participants Group. 2001. Survey of Infections Due to 
Staphylococcus Species: Frequency of Occurrence and Antimicrobial 
Susceptibility of Isolates Collected in the United States, Canada, Latin America, 
Europe, and the Western Pacific Refion for the SENTRY Antimicrobial 
Sueveillance Program, 1997-1999. Clinical Infectious Diseases. 32:114-32. 
           28 
 
 
 
Dunne, M. W., Mason, E. O., and Kaplan, S. L. 1993. Diffusion of Rifampin and 
Vancomycin through a Staphylococcus epidermidis Biofilm. Antimicrobial 
Agents and Chemotherapy. 37:2522-2526. 
Eiff, C. V., Petrs, G., and Heilmann, C. 2002. Pathogenesis of infections due to coagulase 
negative Staphylococci. Infectious Diseases. 2:677-685. 
Gatherer, D. 2009. The 2009 H1N1 influenza outbreak in its historical context. Journal of 
Clinical Virology. 45:174-178. 
Gazzola, S., and Cocconcelli, P. S. 2008. Vancomycin heteroresistance and biofilm 
formation in Staphylococcus epidermidis from food. Microbiology. 154:3224-
3231. 
Gholizadeh, Y., and Courvalin, P. 2000. Acquired and intrinsic glycopeptide resistance in 
enterococci. International Journal of Antimicrobial Agents. 2000. 16:S11-S17. 
Hiramatsu, K. 2001. Vancomycin-Resistant Staphylococcus aureus: a New Model of 
Antibiotic Resistance. The Lancet Infectious Diseases. 1:147-155. 
Hong, H., Hutchings, M. I., and Buttner, M. J. 2008. Vancomycin Resistance VanS/VanR 
Two-Component Systems. Bacterial Signal Transduction: Networks and Drug 
Targets. 631:200-213. 
Irlinger, F. 2008. Safety assessment of dairy microorganisms: Coagulase-negative 
staphylococci. International Journal of Food Microbiology. 126:302-310. 
Jones, R. N. 2008. Key considerations in the treatment of complicated staphylococcal 
infections. Journal Compilation European Society of Clinical Microbiology and 
Infectious Diseases. 14:3-9. 
           29 
 
 
 
Levine, D. P. 2006. Vancomycin: A History. Clinical Infectious Diseases. 42:S5-12. 
McCann, M. T., Gilmore, B. F., and Gorman, S. P. 2008. Staphylococcus epidermidis 
device-related infections: pathogenesis and clinical management. 60:1551-1571. 
Patel, M., Dennis, A., Flutter, C., and Khan, Z. 2010. Pandemic (H1N1) 2009 influenza. 
British Journal of Anaesthesia. 104:128-142. 
Place, R. R., Hiestand, D., Burri, S., and Teuber, M. 2002. Staphylococcus succinus 
subsp. casei. Nov., a Dominant isolate from a Surface Ripened Cheese. 
Systematic and Applied Microbiology. 25:353-359. 
Resch, M., Nagel, V., and Hertel, C. 2008. Antibiotic Resistance of Coagulase-Negative 
Staphylococci Associated with Food and Used in Starter Cultures. International 
Journal of Food Microbiology. 127:99-104. 
Rice, K. C., Mann, E. E., Endres, J. L., Weiss, E. C., Cassat, J. C., Smeltzer, M. S., and 
Balyes, K. W. 2007.  The cidA murein hydrolase regulator contributes to DNA 
release and biofilm development in Staphylococcus aureus. Proceedings of the 
National Academy of Sciences of the United States of America. 104:8113-8118. 
Rice, L. B. 2006. Antimicrobial resistance in gram-positive bacteria. American Journal of  
Infection Control. 5:S-11-19. 
Ryan, K. J., and Ray, G. C. 2010. Sherris Medical Microbiology,  4th Edition: Principles 
Laboratory Diagnosis of Infectious Diseases. McGraw-Hill.  
Schlag, S., Nerz, C., Birkenstock, T. A., Altenberend, F., and Gotz, F. 2007. Inhibition of 
Staphylococcal Biofilm Formation by Nitrite. Journal of Bacteriology. 
1897911-7919. 
           30 
 
 
 
Sieradzki, K., and Tomasz, A. 1997. Inhibition of Cell Wall Turnover and Autolysis by 
Vancomycin in a Highly Vancomycin-Resistant Mutant of Staphylococcus 
aureus. Journal of Bacteriology. 179:2557-2566. 
Stewart, P. S. 2002. Mechanisms of antibiotic resistance in bacterial biofilms. 
International Journal of Microbiology. 292:107-113. 
Thurlow, L. R. and Gillock E. T. 2005. Characterization of   Two Environmental 
Bacterial Isolates by 16S rRNA Sequence Analysis, Fatty Acid Methyl Ester 
Analysis, and Scanning Electron Microscopy. Transactions of the Kansas 
Academy of Science. 108: 22-31. 
Toledo-Arana, A., Valle, J., Solano, C., Arrizubieta, M. J., Cucarella, C., Lamata, M., 
Amorena, B., Leiva, J., Penades, J. R., and Lasa, I. 2001. The Enterococcal 
Surface Protein, Esp, Is Involved in Enterococcus faecalis Biofilm Formation. 
Applied and Environmental Microbiology. 67:4538-4545. 
Tsiodras, S., Kelesidis, T., Kelesidis, L., Bauchinger, ULF., Falagas, M. E. 2008. Human 
Infections Associated with Wild Birds. Journal of Infection. 56:83-98. 
Ubeda, C., Maiques, E., Knecht, E., Lasa, I., Novick, R. P., and Penades, J. R. 2005. 
Antibiotic-induced SOS response promotes horizontal dissemination of 
pathogenicity island-encoded virulence factors in staphylococci. Molecular 
Microbiology. 53:836-844. 
Walsh, T. R., and Howe, R. A. 2002. The Prevalence and Mechanisms of Vancomycin 
Resistance in Staphylococcus aureus. Annual Review Microbiology. 56:657-75. 
Zell, C., Resch, M., Rosenstein, R., Albrecht, T., Hertel, C., and Gotz, F. 2008.  
           31 
 
 
 
Characterization of Toxin Production of Coagulase-Negative Staphylococci 
Isolated From Food and Starter Cultures. International Journal of Food 
Microbiology. 127:246-251.  
 
 
 
 
 
 
 
 
 
 
           32 
 
 
 
 
 
 
Figure 1. Transpeptidase and the mode of action of vancomycin. Transpeptidase 
recognizes the sequence D-Alanyl-D-alanine (D-Ala-D-Ala) at the end of the 
pentapeptide chains, cleaves off the terminal alanine and joins the remainder to the 
branch of a stem peptide from an adjacent polysaccharide chain. Vancomycin binds the 
D-Ala-D-Ala terminus. This interaction blocks formation of mature peptidoglycan, 
denying trandpeptidase access to its substrate. (From Hong et al, 2008). 
 
 
 
 
OH 2 
~ O, . O HNAc 
r o ·Ho~Me I 0 
L-ala 
I 
D-glu 
I 
LL-dpm-gly 
I 
D-ala 
~ o, A 
~ o, o·J__~ -
r o·H~Me r o 
L-ala 
I 
D-ala 
vanco.;;ycin 
·\···············» PIii 
l~CI 
LL!dpm-gly 
I 
D-glu 
I 
·························> Transpeptidase 
I 
D-ala D-glu 
I LL!dpm - gly D-ala I 
\ gly- D-ala LL-dpm -
I + 
D-glu D-ala I 
O~L-ala eoHO 2 
~o, oo 
-H~ HNAc ('OH HNAc 
O~L-ala eoHO 2 
OH O 0 
HNAc ('O HNAc 
           33 
 
 
 
 
 
 
 
Figure 2. The mechanism of vancomycin-resistance in bacteria which carry van genes. 
Vancomycin resistant bacteria change the sequence of dipeptide to D-Alanyl-D-Lactate 
(D-Ala-D-Lac) at the end of the pentapeptide chain. This change lowers the affinity 
between vancomycin and the dipeptide. (From Hong et al, 2008). 
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Figure 3. vanA-type glycopeptide resistance. Top: Mechanism of synthesis of 
peptidoglycan precursors in a vanA-type resistant strain. Bottom: vanA-type glycopeptide 
resistance operon (From Courvalin, 2006). 
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Figure 4. vanB-type glycopeptide resistance. Top: Mechanism of synthesis of 
peptidoglycan precursors in a vanB-type resistant strain. Bottom: vanB-type glycopeptide 
resistance operon (From Courvalin, 2006). 
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Figure 5. vanD-type strain and vancomycin-dependent strain. Top: Synthesis of 
peptidoglycan precursors in a vanD-type resistant strain. Bottom: Organization of the 
vanD operon. Due to the inactivation of the host chromosomal D-Ala-D-Ala ligase (Ddl), 
the presence of vancomycin in the culture medium is required to induce expression of the 
resistance pathway, thus allowing cell wall synthesis (From Courvalin, 2006). 
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Figure 6. Agarose gel showing PCR detection of the vanA gene. Lane1) 100 bp DNA 
ladder, Lane 2) Enterococcus faecalis SFV1 as positive control of vanA, Lane3) 
Staphylococcus saprophyticus isolate V22, Lane 4) Staphylococcus succinus isolateV45. 
The bands in 100 bp ladder are (starting from the top):1,500, 1,000, 900, 800, 700, 600, 
500, 400, 300, 200, and 100 bp.  
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Figure 7. Agarose gel showing PCR detection of the vanB gene. Lane 1) 100bp DNA 
ladder, Lane 3) Enterococcus faecalis V583 (Positive control), Lane 5) Staphylococcus 
succinus isolate V46. 
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Figure 8. Agarose gel showing PCR detection of  the vanC gene. Lane 1) 100 bp DNA 
ladder, Lane 4) Enterococcus gallinarum ATCC 49579 (Positive control), Lane 7) 
Enterococcus gallinarum isolateV49. 
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 Isolates V56 V154 V163 
ATCC 
12228 
ATCC 
35984 
Absorbance 
at 620nm 
Trial1 0.840 0.688 0.717 0.177 0.632 
Trial 2 0.801 0.631 0.647 0.162 0.647 
 
Figure 9. Crystal Violet Assay for determination of biofilm formation. In this assay, 
Staphylococcus epidermidis ATCC 122288 was used as the negative control and 
Staphylococcus epidermidis ATCC 35984 was used the positive control.  Staphylococcus 
succinus isolate V56 (indicated in the upper left well) clearly demonstrates biofilm 
formation. The table shows the absorbance of each well at 620nm. From this result, the 
isolate V56, isolate V154, and isolate V163 clearly form biofilm since the absorbance 
values of those wells are similar to the absorbance of ATCC 35984. 
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Figure 10. Scanning electron micrograph of Staphylococcus succinus isolate V56. The 
micrograph was taken at 3,800 X magnification. From this micrograph, V56 clearly 
forms a biofilm which covers the cocci-shaped bacterial cells. Scale bar equals 
approximately 2.0µm. 
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Figure 11. Scanning electron micrograph of the biofilm negative control strain, 
Staphylococcus epidermidis ATCC 12228. The micrograph was taken at 10,100 X 
magnification.  From this micrograph, no biofilm structure is observed. Scale bar equals 
approximately 2.0µm. 
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Figure 12. Scanning electron micrograph of the biofilm positive control strain, 
Staphylococcus epidermidis ATCC 35984. The micrograph was taken at 10,500 X 
magnification. From this micrograph, ATCC 35984 clearly forms a biofilm which covers 
the cocci-shaped bacterial cells. Scale bar equals approximately 2.0µm. 
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Gene Primer  Sequence (5’-3’) 
vanA 
EA1(Forward) GGGAAAACGACAATTGC 
EA2 (Reverse) GTACAATGCGGCCGTTA 
vanB 
EB3 (Forward) ACGGAATGGGAAGCCGA 
EB4(Reverse) TGCACCCGATTTCGTTC 
vanC 
EC5(Forward) ATGGATTGGTACTGGTAT 
EC8(Reverse) TAGCGGGAGTGACCAGTAA 
vanD 
ED1(Forward) TGTGGGATGCGATATTCAA 
ED2(Reverse) TGCAGCCAAGTATCCGGTAA 
 
Table 1. Table showing the primers used for the PCR detection of the van genes in this 
study (From Depardieu 2004b). 
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        Table 2. Summary of results showing species of vancomycin-resistant bacteria,  
        isolate number, presence of coagulase activity, MIC of vancomycin activity, bird species 
        the bacteria were isolated from, type of van genes detected, and presence of biofilm.  
Bacteria 
Species 
Isolate 
Number 
Coagulase MIC 
( µg/mL) 
Bird species van genes Biofilm 
Staphylococcus 
saprophyticus 
V22 - ≥ 256 American Robin A - 
Staphylococcus 
succinus 
V45 + ≥ 256 American Robin A - 
Staphylococcus 
succinus 
V46 - ≥ 256 American Robin A, B, and C - 
Staphylococcus 
succinus 
V47 - ≥ 256 American Robin - - 
Enterococcus 
gallinarum 
V49 - ≥ 256 American Robin C - 
Staphylococcus 
succinus 
V54 - ≥ 256 American Robin A - 
Staphylococcus 
succinus 
V56 - ≥ 256 American Robin - + 
Staphylococcus 
succinus 
V67 - ≥ 256 American Robin - - 
Staphylococcus 
succinus 
V185 - 1.5 Carolina Wren A - 
Staphylococcus 
succinus 
V163 - ≥ 256 Least Flycatcher - + 
Staphylococcus 
succinus 
V154 + 1.7 Mourning Warbler - + 
Staphylococcus 
succinus 
V187 - ≥ 256 Orange-crowned Warbler 
A - 
Staphylococcus 
succinus 
V166 - ≥ 256 Orange-crowned Warbler - - 
Staphylococcus 
succinus 
V170 - ≥ 256 Orange-crowned Warbler - - 
Staphylococcus 
succinus 
V186 + 2.0 Swainson’s Thrush - - 
Staphylococcus 
succinus 
V183 - ≥ 256 Swainson’s Thrush - - 
